Trypanosomiasis: Clinical Trials

10 trials for Trypanosomiasis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

8 completed, 1 terminated, 1 unknown. 10 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 410Completed 8, Terminated 1, Unknown 1

Follow Trypanosomiasis: new trials by email Literature Review of Trypanosomiasis trials Research Report on Trypanosomiasis

Trials (filtered) newest first · largest first

All 10 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy and Safety of Sacubitril/Valsartan Compared With Enalapril on Morbidity, Mortality, and NT-proBNP Change in Patients With CCC
Sacubitril/valsartan, Enalapril - Chagas Disease, Heart Failure
Phase 4CompletedNovartis Pharmaceuticals9222019-12-102026-05-11
Reveal Chagas: Clinical Evidence of the Implantable Cardiac Monitor in Patients With Chagas Disease
Implantable Cardiac Monitor, Standard of Care - Chagas Disease, Heart Diseases
Phase 4TerminatedMedtronic Cardiac Rhythm and Heart Failure122013-07-012016-10-12
Population Pharmacokinetics in Benznidazole-treated Adults With Chronic With Chagas Disease
Benznidazole - Chagas Disease
Phase 4CompletedBarcelona Centre for International Health Research522012-12-012015-05-27
Clinical Assessment, Neuroimaging and Immunomarkers in Chagas Disease Study (CLINICS)
Aspirin - Chagas Disease With Heart Failure
Phase 4UnknownFederal University of Bahia5002012-07-012023-03-03
Population Pharmacokinetics Study of Benznidazole in Children With Chagas'Disease
Benznidazole 12,5mg or 100mg - Chagas' Disease
Phase 4CompletedDrugs for Neglected Diseases802011-05-012018-06-25
Optimization of PCR Technique to Assess Parasitological Response for Patients With Chronic Chagas Disease
Benznidazole - Chagas Disease
Phase 4CompletedDrugs for Neglected Diseases2202011-04-012018-06-25
Outcomes of an Anticoagulation Clinic in an University Hospital
Anticoagulation clinic, Standard anticoagulation care - Cardiopathy, Chagas Disease
Phase 4CompletedFederal University of Minas Gerais2802009-11-012011-10-25
Clinical Study to Assess the Tolerability, Feasibility and Effectiveness of Nifurtimox and Eflornithine (NECT) for the Treatment of Trypanosoma Brucei Gambiense Human African Trypanosomiasis (HAT) in the Meningo-encephalitic Phase
Nifurtimox-Eflronithine Combination Treatment (NECT) - Human African Trypanosomiasis
Phase 4CompletedDrugs for Neglected Diseases6302009-04-012013-05-31
Exercise Training in Chagas Cardiomyopathy
Exercise training - Chagas Disease, Cardiomyopathy
Phase 4CompletedFederal University of Minas Gerais372007-03-012015-08-13
A Randomized Trial of Carvedilol in Chronic Chagas Cardiomyopathy
RASi plus carvedilol - Chagas Cardiomyopathy, Heart Failure
Phase 4CompletedFederal University of Minas Gerais422003-05-012015-08-13

Narrower conditions

Chagas Disease (8)  ·  Heart Failure (3)  ·  Chagas Cardiomyopathy (2)  ·  Heart Diseases (2)  ·  Cardiomyopathies (1)  ·  Cardiomyopathy, Dilated (1)  ·  Dementia (1)  ·  Disease (1)  ·  Hemorrhage (1)  ·  Stroke (1)  ·  Thrombosis (1)  ·  Trypanosomiasis, African (1)

Broader conditions

Euglenozoa Infections (10)  ·  Infections (10)  ·  Parasitic Diseases (10)  ·  Protozoan Infections (10)  ·  Vector Borne Diseases (10)  ·  Cardiovascular Diseases (6)  ·  Heart Diseases (4)  ·  Pathologic Processes (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Vascular Diseases (2)  ·  Brain Diseases (1)  ·  Cardiomegaly (1)  ·  Cardiomyopathies (1)  ·  Central Nervous System Diseases (1)

Interventions

benzonidazole (2)  ·  Aspirin (1)  ·  Carvedilol (1)  ·  Clinical Trials as Topic (1)  ·  Control Groups (1)  ·  Double-Blind Method (1)  ·  Eflornithine (1)  ·  Enalapril (1)  ·  Exercise (1)  ·  Nifurtimox (1)  ·  Random Allocation (1)  ·  Standard of Care (1)  ·  sacubitril and valsartan sodium hydrate drug combination (1)

Sponsors

Drugs for Neglected Diseases (3)  ·  Federal University of Minas Gerais (3)  ·  Barcelona Centre for International Health Research (1)  ·  Federal University of Bahia (1)  ·  Medtronic Cardiac Rhythm and Heart Failure (1)  ·  Novartis Pharmaceuticals (1)

Countries

Brazil (5)  ·  Argentina (3)  ·  Colombia (2)  ·  Bolivia (1)  ·  Mexico (1)  ·  Republic of the Congo (1)  ·  Spain (1)

Top investigators

Antonio L Ribeiro, MD, PhD (2)  ·  Claudio Muratore, MD (1)  ·  Daniel D Ribeiro, Physician (1)  ·  Diego Venagas, MD (1)  ·  Fernando A Botoni, MD, PhD (1)  ·  Jaime Altcheh, MD (1)  ·  Jamary Oliveira-Filho, MD, PhD (1)  ·  Johannes Blum, MD (1)  ·  Jose Carlos Pachon Mateos, MD (1)  ·  Lourdes Loza, Biochemist (1)  ·  Luis Medesani, MD (1)  ·  Maria Auxiliadora P Martins, Pharmacist (1)

Results publications

PMID 17383291, PMID 20412275, PMID 20675669, PMID 23209861, PMID 23232458, PMID 25098373, PMID 25824212, PMID 29351667, PMID 30509941, PMID 31986140, PMID 34748572, PMID 37256863, PMID 39111953, PMID 41335448

NIH funding

R01NS064905 (1)